“Health of MNJTF Troops remain top priority” – Commander

“Health of MNJTF Troops remain top priority” – Commander

The Force Commander (FC) Multinational Joint Task Force (MNJTF) Major General Abdul Khalifah has assured wounded in action soldiers of the provision of the best medical treatment for their quick recovery, emphasizing that troops health and wellbeing remain the top priority of the Force.

In a statement by the Chief of Military Public Information HQ MNJTF, N’Djamena Chad, Colonel Muhammad Dole, General Abdul Khalifah gave the assurance when he visited soldiers of the MNJTF who are receiving treatment at Renaissance Hospital in N’Djamena Chad on 8 February 2022.

The Commander while comforting the injured soldiers praised their uncommon bravery and patriotism in the face of imminent danger and risks on the battlefield.

The Major General Khalifah who was accompanied by the MNJTF Chief Medical Officer, Colonel Boubakar Siddo, Director General of the Hospital Ali Mahamat Djibrine and some Military Staff Officers, toured the hospital wards where the soldiers from Cameroon, Chad and Niger republics are being treated for the injuries sustained from the ongoing operation in Lake Chad Basin.

He further stated that despite the mass surrender by the insurgents, operations would continue until they totally surrender or are totally defeated.

According to the statement, the injured soldiers were visibly glad and felt inspired by the visit as well as the encouraging words and care displayed by the leadership of the MNJTF.

While interacting with the hospital management, General Khalifah expressed satisfaction with the level of professional conduct and commitment of the staff in handling the patients and promised to continue to work together for the provision of efficient medical services to the wounded soldiers.

 
PIAK
“Health of MNJTF Troops remain top priority” – Commander

Breaking News

TDPel Media

This article was published on TDPel Media. Thanks for reading!

Share on Facebook «||» Share on Twitter «||» Share on Reddit «||» Share on LinkedIn